nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Topoisomerase Inhibitors—Etoposide—germ cell cancer	0.676	1	CiPCiCtD
Idarubicin—TOP2A—Etoposide—germ cell cancer	0.0581	0.245	CbGbCtD
Idarubicin—ABCC1—Dactinomycin—germ cell cancer	0.0571	0.24	CbGbCtD
Idarubicin—ABCC1—Vinblastine—germ cell cancer	0.0358	0.151	CbGbCtD
Idarubicin—ABCC1—Etoposide—germ cell cancer	0.0322	0.136	CbGbCtD
Idarubicin—ABCC1—Methotrexate—germ cell cancer	0.0213	0.0896	CbGbCtD
Idarubicin—CYP2C9—Ifosfamide—germ cell cancer	0.0168	0.0705	CbGbCtD
Idarubicin—CYP2C9—Cisplatin—germ cell cancer	0.00815	0.0343	CbGbCtD
Idarubicin—CYP2D6—Vinblastine—germ cell cancer	0.00813	0.0342	CbGbCtD
Idarubicin—CYP2C9—cardial valve—germ cell cancer	0.00202	0.358	CbGeAlD
Idarubicin—TOP2A—Vindesine—Vinblastine—germ cell cancer	0.000497	0.291	CbGdCrCtD
Idarubicin—CYP2C9—urine—germ cell cancer	0.000436	0.0771	CbGeAlD
Idarubicin—Necrosis—Dactinomycin—germ cell cancer	0.00043	0.00544	CcSEcCtD
Idarubicin—Fluid overload—Cisplatin—germ cell cancer	0.000428	0.00543	CcSEcCtD
Idarubicin—Lymphoma—Methotrexate—germ cell cancer	0.000418	0.0053	CcSEcCtD
Idarubicin—Extravasation—Bleomycin—germ cell cancer	0.000414	0.00525	CcSEcCtD
Idarubicin—Febrile neutropenia—Etoposide—germ cell cancer	0.000406	0.00514	CcSEcCtD
Idarubicin—Necrosis—Ifosfamide—germ cell cancer	0.000394	0.00499	CcSEcCtD
Idarubicin—Neoplasm—Vinblastine—germ cell cancer	0.000387	0.0049	CcSEcCtD
Idarubicin—Extravasation—Dactinomycin—germ cell cancer	0.000386	0.0049	CcSEcCtD
Idarubicin—Ulcer—Bleomycin—germ cell cancer	0.000382	0.00484	CcSEcCtD
Idarubicin—Phlebitis—Vinblastine—germ cell cancer	0.000361	0.00457	CcSEcCtD
Idarubicin—Ulcer—Dactinomycin—germ cell cancer	0.000356	0.00452	CcSEcCtD
Idarubicin—Extravasation—Ifosfamide—germ cell cancer	0.000354	0.00449	CcSEcCtD
Idarubicin—Necrosis—Cisplatin—germ cell cancer	0.000339	0.0043	CcSEcCtD
Idarubicin—Pericarditis—Methotrexate—germ cell cancer	0.000338	0.00428	CcSEcCtD
Idarubicin—CYP2D6—urine—germ cell cancer	0.000327	0.0579	CbGeAlD
Idarubicin—TOP2A—Vinorelbine—Vinblastine—germ cell cancer	0.000314	0.184	CbGdCrCtD
Idarubicin—TOP2A—Teniposide—Etoposide—germ cell cancer	0.000313	0.184	CbGdCrCtD
Idarubicin—TOP2A—Podofilox—Etoposide—germ cell cancer	0.000313	0.184	CbGdCrCtD
Idarubicin—Necrosis—Etoposide—germ cell cancer	0.000311	0.00394	CcSEcCtD
Idarubicin—Oesophagitis—Dactinomycin—germ cell cancer	0.000308	0.0039	CcSEcCtD
Idarubicin—Extravasation—Cisplatin—germ cell cancer	0.000305	0.00387	CcSEcCtD
Idarubicin—Phlebitis—Bleomycin—germ cell cancer	0.000305	0.00386	CcSEcCtD
Idarubicin—Colitis—Ifosfamide—germ cell cancer	0.000297	0.00376	CcSEcCtD
Idarubicin—Sepsis—Dactinomycin—germ cell cancer	0.000293	0.00371	CcSEcCtD
Idarubicin—Hyperuricaemia—Cisplatin—germ cell cancer	0.000287	0.00364	CcSEcCtD
Idarubicin—Phlebitis—Dactinomycin—germ cell cancer	0.000284	0.0036	CcSEcCtD
Idarubicin—Ulcer—Cisplatin—germ cell cancer	0.000282	0.00357	CcSEcCtD
Idarubicin—Extravasation—Etoposide—germ cell cancer	0.00028	0.00354	CcSEcCtD
Idarubicin—Neoplasm—Ifosfamide—germ cell cancer	0.000279	0.00354	CcSEcCtD
Idarubicin—Blood uric acid increased—Cisplatin—germ cell cancer	0.000271	0.00344	CcSEcCtD
Idarubicin—Sepsis—Ifosfamide—germ cell cancer	0.000268	0.0034	CcSEcCtD
Idarubicin—TOP2A—Vincristine—Vinblastine—germ cell cancer	0.000268	0.157	CbGdCrCtD
Idarubicin—Mucosal inflammation—Methotrexate—germ cell cancer	0.000264	0.00335	CcSEcCtD
Idarubicin—Hyperuricaemia—Etoposide—germ cell cancer	0.000263	0.00333	CcSEcCtD
Idarubicin—Phlebitis—Ifosfamide—germ cell cancer	0.00026	0.0033	CcSEcCtD
Idarubicin—Thrombophlebitis—Ifosfamide—germ cell cancer	0.000259	0.00328	CcSEcCtD
Idarubicin—Ulcer—Etoposide—germ cell cancer	0.000258	0.00327	CcSEcCtD
Idarubicin—Hepatic function abnormal—Ifosfamide—germ cell cancer	0.000257	0.00325	CcSEcCtD
Idarubicin—Pancytopenia—Vinblastine—germ cell cancer	0.000255	0.00323	CcSEcCtD
Idarubicin—Blood uric acid increased—Etoposide—germ cell cancer	0.000249	0.00315	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Methotrexate—germ cell cancer	0.000246	0.00311	CcSEcCtD
Idarubicin—Febrile neutropenia—Methotrexate—germ cell cancer	0.000243	0.00308	CcSEcCtD
Idarubicin—TOP2A—decidua—germ cell cancer	0.000239	0.0422	CbGeAlD
Idarubicin—Atrial fibrillation—Ifosfamide—germ cell cancer	0.000237	0.003	CcSEcCtD
Idarubicin—Acute coronary syndrome—Vinblastine—germ cell cancer	0.000236	0.00299	CcSEcCtD
Idarubicin—Myocardial infarction—Vinblastine—germ cell cancer	0.000235	0.00297	CcSEcCtD
Idarubicin—Embolism—Methotrexate—germ cell cancer	0.000228	0.00289	CcSEcCtD
Idarubicin—Phlebitis—Cisplatin—germ cell cancer	0.000224	0.00284	CcSEcCtD
Idarubicin—Oesophagitis—Etoposide—germ cell cancer	0.000223	0.00283	CcSEcCtD
Idarubicin—Bone marrow depression—Methotrexate—germ cell cancer	0.000217	0.00274	CcSEcCtD
Idarubicin—Haemoglobin—Vinblastine—germ cell cancer	0.000216	0.00274	CcSEcCtD
Idarubicin—Pancytopenia—Bleomycin—germ cell cancer	0.000215	0.00273	CcSEcCtD
Idarubicin—Haemorrhage—Vinblastine—germ cell cancer	0.000215	0.00272	CcSEcCtD
Idarubicin—Cardiac failure congestive—Cisplatin—germ cell cancer	0.000213	0.0027	CcSEcCtD
Idarubicin—Sepsis—Etoposide—germ cell cancer	0.000212	0.00268	CcSEcCtD
Idarubicin—Burning sensation—Methotrexate—germ cell cancer	0.00021	0.00267	CcSEcCtD
Idarubicin—TOP2A—uterus—germ cell cancer	0.000209	0.0369	CbGeAlD
Idarubicin—Phlebitis—Etoposide—germ cell cancer	0.000206	0.00261	CcSEcCtD
Idarubicin—Pancytopenia—Dactinomycin—germ cell cancer	0.000201	0.00255	CcSEcCtD
Idarubicin—Acute coronary syndrome—Bleomycin—germ cell cancer	0.000199	0.00253	CcSEcCtD
Idarubicin—Myocardial infarction—Bleomycin—germ cell cancer	0.000198	0.00251	CcSEcCtD
Idarubicin—Neutropenia—Dactinomycin—germ cell cancer	0.000198	0.00251	CcSEcCtD
Idarubicin—Stomatitis—Bleomycin—germ cell cancer	0.000197	0.0025	CcSEcCtD
Idarubicin—Cardiac failure congestive—Etoposide—germ cell cancer	0.000195	0.00247	CcSEcCtD
Idarubicin—Alopecia—Vinblastine—germ cell cancer	0.00019	0.00241	CcSEcCtD
Idarubicin—Necrosis—Methotrexate—germ cell cancer	0.000186	0.00236	CcSEcCtD
Idarubicin—Pancytopenia—Ifosfamide—germ cell cancer	0.000184	0.00233	CcSEcCtD
Idarubicin—Stomatitis—Dactinomycin—germ cell cancer	0.000184	0.00233	CcSEcCtD
Idarubicin—TOP2A—adrenal gland—germ cell cancer	0.000183	0.0324	CbGeAlD
Idarubicin—Haemoglobin—Bleomycin—germ cell cancer	0.000182	0.00231	CcSEcCtD
Idarubicin—Haemorrhage—Bleomycin—germ cell cancer	0.000182	0.0023	CcSEcCtD
Idarubicin—Dehydration—Cisplatin—germ cell cancer	0.00018	0.00228	CcSEcCtD
Idarubicin—TOP2A—bone marrow—germ cell cancer	0.000177	0.0313	CbGeAlD
Idarubicin—Anaemia—Vinblastine—germ cell cancer	0.000173	0.00219	CcSEcCtD
Idarubicin—TOP2A—female gonad—germ cell cancer	0.000171	0.0302	CbGeAlD
Idarubicin—Acute coronary syndrome—Ifosfamide—germ cell cancer	0.00017	0.00216	CcSEcCtD
Idarubicin—Myocardial infarction—Ifosfamide—germ cell cancer	0.000169	0.00215	CcSEcCtD
Idarubicin—Flushing—Bleomycin—germ cell cancer	0.000169	0.00213	CcSEcCtD
Idarubicin—Stomatitis—Ifosfamide—germ cell cancer	0.000168	0.00213	CcSEcCtD
Idarubicin—Extravasation—Methotrexate—germ cell cancer	0.000168	0.00212	CcSEcCtD
Idarubicin—Leukopenia—Vinblastine—germ cell cancer	0.000168	0.00212	CcSEcCtD
Idarubicin—Chills—Bleomycin—germ cell cancer	0.000163	0.00206	CcSEcCtD
Idarubicin—Convulsion—Vinblastine—germ cell cancer	0.000162	0.00205	CcSEcCtD
Idarubicin—Alopecia—Bleomycin—germ cell cancer	0.00016	0.00203	CcSEcCtD
Idarubicin—Pancytopenia—Cisplatin—germ cell cancer	0.000159	0.00201	CcSEcCtD
Idarubicin—Hyperuricaemia—Methotrexate—germ cell cancer	0.000158	0.002	CcSEcCtD
Idarubicin—Flushing—Dactinomycin—germ cell cancer	0.000157	0.00199	CcSEcCtD
Idarubicin—Haemoglobin—Ifosfamide—germ cell cancer	0.000156	0.00198	CcSEcCtD
Idarubicin—Haemorrhage—Ifosfamide—germ cell cancer	0.000155	0.00197	CcSEcCtD
Idarubicin—Ulcer—Methotrexate—germ cell cancer	0.000155	0.00196	CcSEcCtD
Idarubicin—Urinary tract disorder—Ifosfamide—germ cell cancer	0.000153	0.00194	CcSEcCtD
Idarubicin—Urethral disorder—Ifosfamide—germ cell cancer	0.000152	0.00193	CcSEcCtD
Idarubicin—Chills—Dactinomycin—germ cell cancer	0.000152	0.00192	CcSEcCtD
Idarubicin—ABCC1—telencephalon—germ cell cancer	0.000152	0.0268	CbGeAlD
Idarubicin—TOP2A—testis—germ cell cancer	0.000151	0.0268	CbGeAlD
Idarubicin—Alopecia—Dactinomycin—germ cell cancer	0.00015	0.0019	CcSEcCtD
Idarubicin—Thrombocytopenia—Vinblastine—germ cell cancer	0.00015	0.00189	CcSEcCtD
Idarubicin—Blood uric acid increased—Methotrexate—germ cell cancer	0.000149	0.00189	CcSEcCtD
Idarubicin—Acute coronary syndrome—Cisplatin—germ cell cancer	0.000147	0.00186	CcSEcCtD
Idarubicin—Anaemia—Bleomycin—germ cell cancer	0.000146	0.00185	CcSEcCtD
Idarubicin—Myocardial infarction—Cisplatin—germ cell cancer	0.000146	0.00185	CcSEcCtD
Idarubicin—Anorexia—Vinblastine—germ cell cancer	0.000146	0.00184	CcSEcCtD
Idarubicin—Pancytopenia—Etoposide—germ cell cancer	0.000145	0.00184	CcSEcCtD
Idarubicin—Stomatitis—Cisplatin—germ cell cancer	0.000145	0.00184	CcSEcCtD
Idarubicin—Flushing—Ifosfamide—germ cell cancer	0.000144	0.00182	CcSEcCtD
Idarubicin—ABCC1—decidua—germ cell cancer	0.000144	0.0254	CbGeAlD
Idarubicin—Neutropenia—Etoposide—germ cell cancer	0.000143	0.00181	CcSEcCtD
Idarubicin—Leukopenia—Bleomycin—germ cell cancer	0.000141	0.00179	CcSEcCtD
Idarubicin—Angiopathy—Ifosfamide—germ cell cancer	0.000141	0.00178	CcSEcCtD
Idarubicin—Immune system disorder—Ifosfamide—germ cell cancer	0.00014	0.00178	CcSEcCtD
Idarubicin—Chills—Ifosfamide—germ cell cancer	0.000139	0.00176	CcSEcCtD
Idarubicin—Arrhythmia—Ifosfamide—germ cell cancer	0.000139	0.00176	CcSEcCtD
Idarubicin—Alopecia—Ifosfamide—germ cell cancer	0.000137	0.00174	CcSEcCtD
Idarubicin—Anaemia—Dactinomycin—germ cell cancer	0.000136	0.00173	CcSEcCtD
Idarubicin—Malnutrition—Ifosfamide—germ cell cancer	0.000135	0.00171	CcSEcCtD
Idarubicin—Acute coronary syndrome—Etoposide—germ cell cancer	0.000135	0.00171	CcSEcCtD
Idarubicin—Chest pain—Bleomycin—germ cell cancer	0.000135	0.0017	CcSEcCtD
Idarubicin—Myocardial infarction—Etoposide—germ cell cancer	0.000134	0.0017	CcSEcCtD
Idarubicin—Stomatitis—Etoposide—germ cell cancer	0.000133	0.00169	CcSEcCtD
Idarubicin—Decreased appetite—Vinblastine—germ cell cancer	0.000133	0.00168	CcSEcCtD
Idarubicin—Neoplasm—Methotrexate—germ cell cancer	0.000132	0.00167	CcSEcCtD
Idarubicin—Urinary tract disorder—Cisplatin—germ cell cancer	0.000132	0.00167	CcSEcCtD
Idarubicin—Leukopenia—Dactinomycin—germ cell cancer	0.000132	0.00167	CcSEcCtD
Idarubicin—Urethral disorder—Cisplatin—germ cell cancer	0.000131	0.00166	CcSEcCtD
Idarubicin—Anaphylactic shock—Bleomycin—germ cell cancer	0.000129	0.00163	CcSEcCtD
Idarubicin—Infection—Bleomycin—germ cell cancer	0.000128	0.00162	CcSEcCtD
Idarubicin—Sepsis—Methotrexate—germ cell cancer	0.000127	0.00161	CcSEcCtD
Idarubicin—Thrombocytopenia—Bleomycin—germ cell cancer	0.000126	0.0016	CcSEcCtD
Idarubicin—ABCC1—uterus—germ cell cancer	0.000126	0.0222	CbGeAlD
Idarubicin—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000125	0.00158	CcSEcCtD
Idarubicin—Anaemia—Ifosfamide—germ cell cancer	0.000125	0.00158	CcSEcCtD
Idarubicin—Flushing—Cisplatin—germ cell cancer	0.000124	0.00157	CcSEcCtD
Idarubicin—ABCC1—pituitary gland—germ cell cancer	0.000123	0.0218	CbGeAlD
Idarubicin—Anorexia—Bleomycin—germ cell cancer	0.000123	0.00156	CcSEcCtD
Idarubicin—Thrombophlebitis—Methotrexate—germ cell cancer	0.000123	0.00155	CcSEcCtD
Idarubicin—Urinary tract disorder—Etoposide—germ cell cancer	0.000121	0.00153	CcSEcCtD
Idarubicin—Leukopenia—Ifosfamide—germ cell cancer	0.000121	0.00153	CcSEcCtD
Idarubicin—Immune system disorder—Cisplatin—germ cell cancer	0.000121	0.00153	CcSEcCtD
Idarubicin—Abdominal pain—Vinblastine—germ cell cancer	0.000121	0.00153	CcSEcCtD
Idarubicin—Urethral disorder—Etoposide—germ cell cancer	0.00012	0.00152	CcSEcCtD
Idarubicin—Infection—Dactinomycin—germ cell cancer	0.00012	0.00151	CcSEcCtD
Idarubicin—Arrhythmia—Cisplatin—germ cell cancer	0.00012	0.00151	CcSEcCtD
Idarubicin—Alopecia—Cisplatin—germ cell cancer	0.000118	0.0015	CcSEcCtD
Idarubicin—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000118	0.00149	CcSEcCtD
Idarubicin—Convulsion—Ifosfamide—germ cell cancer	0.000117	0.00148	CcSEcCtD
Idarubicin—Malnutrition—Cisplatin—germ cell cancer	0.000116	0.00148	CcSEcCtD
Idarubicin—Chest pain—Ifosfamide—germ cell cancer	0.000115	0.00146	CcSEcCtD
Idarubicin—Anorexia—Dactinomycin—germ cell cancer	0.000115	0.00145	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000114	0.00145	CcSEcCtD
Idarubicin—Flushing—Etoposide—germ cell cancer	0.000114	0.00144	CcSEcCtD
Idarubicin—Hypersensitivity—Vinblastine—germ cell cancer	0.000113	0.00143	CcSEcCtD
Idarubicin—Decreased appetite—Bleomycin—germ cell cancer	0.000112	0.00142	CcSEcCtD
Idarubicin—Angiopathy—Etoposide—germ cell cancer	0.000111	0.00141	CcSEcCtD
Idarubicin—Immune system disorder—Etoposide—germ cell cancer	0.000111	0.0014	CcSEcCtD
Idarubicin—ABCC1—adrenal gland—germ cell cancer	0.00011	0.0195	CbGeAlD
Idarubicin—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00011	0.0014	CcSEcCtD
Idarubicin—Chills—Etoposide—germ cell cancer	0.00011	0.00139	CcSEcCtD
Idarubicin—TOP2A—lymph node—germ cell cancer	0.00011	0.0194	CbGeAlD
Idarubicin—Infection—Ifosfamide—germ cell cancer	0.00011	0.00139	CcSEcCtD
Idarubicin—Alopecia—Etoposide—germ cell cancer	0.000108	0.00137	CcSEcCtD
Idarubicin—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000108	0.00137	CcSEcCtD
Idarubicin—Anaemia—Cisplatin—germ cell cancer	0.000108	0.00136	CcSEcCtD
Idarubicin—Skin disorder—Ifosfamide—germ cell cancer	0.000107	0.00136	CcSEcCtD
Idarubicin—Anorexia—Ifosfamide—germ cell cancer	0.000105	0.00133	CcSEcCtD
Idarubicin—Decreased appetite—Dactinomycin—germ cell cancer	0.000105	0.00132	CcSEcCtD
Idarubicin—Diarrhoea—Vinblastine—germ cell cancer	0.000104	0.00132	CcSEcCtD
Idarubicin—Leukopenia—Cisplatin—germ cell cancer	0.000104	0.00132	CcSEcCtD
Idarubicin—ABCC1—female gonad—germ cell cancer	0.000103	0.0182	CbGeAlD
Idarubicin—Urticaria—Bleomycin—germ cell cancer	0.000102	0.0013	CcSEcCtD
Idarubicin—Body temperature increased—Bleomycin—germ cell cancer	0.000102	0.00129	CcSEcCtD
Idarubicin—Convulsion—Cisplatin—germ cell cancer	0.000101	0.00128	CcSEcCtD
Idarubicin—Anaemia—Etoposide—germ cell cancer	9.86e-05	0.00125	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	9.85e-05	0.00125	CcSEcCtD
Idarubicin—Gastrointestinal pain—Dactinomycin—germ cell cancer	9.84e-05	0.00125	CcSEcCtD
Idarubicin—Vomiting—Vinblastine—germ cell cancer	9.71e-05	0.00123	CcSEcCtD
Idarubicin—CYP2D6—brainstem—germ cell cancer	9.7e-05	0.0171	CbGeAlD
Idarubicin—Decreased appetite—Ifosfamide—germ cell cancer	9.58e-05	0.00121	CcSEcCtD
Idarubicin—Headache—Vinblastine—germ cell cancer	9.57e-05	0.00121	CcSEcCtD
Idarubicin—Leukopenia—Etoposide—germ cell cancer	9.55e-05	0.00121	CcSEcCtD
Idarubicin—Abdominal pain—Dactinomycin—germ cell cancer	9.51e-05	0.0012	CcSEcCtD
Idarubicin—Body temperature increased—Dactinomycin—germ cell cancer	9.51e-05	0.0012	CcSEcCtD
Idarubicin—Anaphylactic shock—Cisplatin—germ cell cancer	9.5e-05	0.0012	CcSEcCtD
Idarubicin—Hypersensitivity—Bleomycin—germ cell cancer	9.5e-05	0.0012	CcSEcCtD
Idarubicin—Infection—Cisplatin—germ cell cancer	9.44e-05	0.0012	CcSEcCtD
Idarubicin—Thrombocytopenia—Cisplatin—germ cell cancer	9.31e-05	0.00118	CcSEcCtD
Idarubicin—Convulsion—Etoposide—germ cell cancer	9.24e-05	0.00117	CcSEcCtD
Idarubicin—Skin disorder—Cisplatin—germ cell cancer	9.23e-05	0.00117	CcSEcCtD
Idarubicin—ABCC1—testis—germ cell cancer	9.12e-05	0.0161	CbGeAlD
Idarubicin—Chest pain—Etoposide—germ cell cancer	9.08e-05	0.00115	CcSEcCtD
Idarubicin—Nausea—Vinblastine—germ cell cancer	9.07e-05	0.00115	CcSEcCtD
Idarubicin—Anorexia—Cisplatin—germ cell cancer	9.06e-05	0.00115	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	9.02e-05	0.00114	CcSEcCtD
Idarubicin—Gastrointestinal pain—Ifosfamide—germ cell cancer	9.01e-05	0.00114	CcSEcCtD
Idarubicin—Hypersensitivity—Dactinomycin—germ cell cancer	8.86e-05	0.00112	CcSEcCtD
Idarubicin—Urticaria—Ifosfamide—germ cell cancer	8.76e-05	0.00111	CcSEcCtD
Idarubicin—Abdominal pain—Ifosfamide—germ cell cancer	8.71e-05	0.0011	CcSEcCtD
Idarubicin—Body temperature increased—Ifosfamide—germ cell cancer	8.71e-05	0.0011	CcSEcCtD
Idarubicin—Pancytopenia—Methotrexate—germ cell cancer	8.71e-05	0.0011	CcSEcCtD
Idarubicin—Anaphylactic shock—Etoposide—germ cell cancer	8.71e-05	0.0011	CcSEcCtD
Idarubicin—Infection—Etoposide—germ cell cancer	8.65e-05	0.0011	CcSEcCtD
Idarubicin—CYP2D6—telencephalon—germ cell cancer	8.6e-05	0.0152	CbGeAlD
Idarubicin—Neutropenia—Methotrexate—germ cell cancer	8.58e-05	0.00109	CcSEcCtD
Idarubicin—Thrombocytopenia—Etoposide—germ cell cancer	8.53e-05	0.00108	CcSEcCtD
Idarubicin—Skin disorder—Etoposide—germ cell cancer	8.46e-05	0.00107	CcSEcCtD
Idarubicin—ABCC1—cerebellum—germ cell cancer	8.42e-05	0.0149	CbGeAlD
Idarubicin—Anorexia—Etoposide—germ cell cancer	8.3e-05	0.00105	CcSEcCtD
Idarubicin—Decreased appetite—Cisplatin—germ cell cancer	8.26e-05	0.00105	CcSEcCtD
Idarubicin—Diarrhoea—Dactinomycin—germ cell cancer	8.23e-05	0.00104	CcSEcCtD
Idarubicin—Vomiting—Bleomycin—germ cell cancer	8.2e-05	0.00104	CcSEcCtD
Idarubicin—Rash—Bleomycin—germ cell cancer	8.13e-05	0.00103	CcSEcCtD
Idarubicin—Dermatitis—Bleomycin—germ cell cancer	8.13e-05	0.00103	CcSEcCtD
Idarubicin—Hypersensitivity—Ifosfamide—germ cell cancer	8.12e-05	0.00103	CcSEcCtD
Idarubicin—Stomatitis—Methotrexate—germ cell cancer	7.97e-05	0.00101	CcSEcCtD
Idarubicin—Nausea—Bleomycin—germ cell cancer	7.66e-05	0.000971	CcSEcCtD
Idarubicin—Vomiting—Dactinomycin—germ cell cancer	7.65e-05	0.000969	CcSEcCtD
Idarubicin—Rash—Dactinomycin—germ cell cancer	7.59e-05	0.000961	CcSEcCtD
Idarubicin—Decreased appetite—Etoposide—germ cell cancer	7.57e-05	0.000959	CcSEcCtD
Idarubicin—Diarrhoea—Ifosfamide—germ cell cancer	7.54e-05	0.000956	CcSEcCtD
Idarubicin—Body temperature increased—Cisplatin—germ cell cancer	7.51e-05	0.000952	CcSEcCtD
Idarubicin—Haemoglobin—Methotrexate—germ cell cancer	7.38e-05	0.000935	CcSEcCtD
Idarubicin—Haemorrhage—Methotrexate—germ cell cancer	7.34e-05	0.00093	CcSEcCtD
Idarubicin—Urinary tract disorder—Methotrexate—germ cell cancer	7.25e-05	0.000918	CcSEcCtD
Idarubicin—CYP2C9—endocrine gland—germ cell cancer	7.23e-05	0.0128	CbGeAlD
Idarubicin—Urethral disorder—Methotrexate—germ cell cancer	7.2e-05	0.000912	CcSEcCtD
Idarubicin—Nausea—Dactinomycin—germ cell cancer	7.15e-05	0.000905	CcSEcCtD
Idarubicin—Gastrointestinal pain—Etoposide—germ cell cancer	7.12e-05	0.000902	CcSEcCtD
Idarubicin—Vomiting—Ifosfamide—germ cell cancer	7.01e-05	0.000888	CcSEcCtD
Idarubicin—Hypersensitivity—Cisplatin—germ cell cancer	7e-05	0.000887	CcSEcCtD
Idarubicin—Rash—Ifosfamide—germ cell cancer	6.95e-05	0.000881	CcSEcCtD
Idarubicin—Dermatitis—Ifosfamide—germ cell cancer	6.94e-05	0.00088	CcSEcCtD
Idarubicin—Urticaria—Etoposide—germ cell cancer	6.92e-05	0.000876	CcSEcCtD
Idarubicin—Body temperature increased—Etoposide—germ cell cancer	6.88e-05	0.000872	CcSEcCtD
Idarubicin—Abdominal pain—Etoposide—germ cell cancer	6.88e-05	0.000872	CcSEcCtD
Idarubicin—ABCC1—brain—germ cell cancer	6.84e-05	0.0121	CbGeAlD
Idarubicin—Angiopathy—Methotrexate—germ cell cancer	6.66e-05	0.000844	CcSEcCtD
Idarubicin—Immune system disorder—Methotrexate—germ cell cancer	6.63e-05	0.00084	CcSEcCtD
Idarubicin—ABCC1—lymph node—germ cell cancer	6.61e-05	0.0117	CbGeAlD
Idarubicin—Chills—Methotrexate—germ cell cancer	6.59e-05	0.000835	CcSEcCtD
Idarubicin—Nausea—Ifosfamide—germ cell cancer	6.55e-05	0.00083	CcSEcCtD
Idarubicin—Diarrhoea—Cisplatin—germ cell cancer	6.5e-05	0.000824	CcSEcCtD
Idarubicin—Alopecia—Methotrexate—germ cell cancer	6.49e-05	0.000822	CcSEcCtD
Idarubicin—Hypersensitivity—Etoposide—germ cell cancer	6.41e-05	0.000813	CcSEcCtD
Idarubicin—Malnutrition—Methotrexate—germ cell cancer	6.39e-05	0.00081	CcSEcCtD
Idarubicin—Vomiting—Cisplatin—germ cell cancer	6.04e-05	0.000766	CcSEcCtD
Idarubicin—Rash—Cisplatin—germ cell cancer	5.99e-05	0.000759	CcSEcCtD
Idarubicin—Dermatitis—Cisplatin—germ cell cancer	5.99e-05	0.000759	CcSEcCtD
Idarubicin—Diarrhoea—Etoposide—germ cell cancer	5.96e-05	0.000755	CcSEcCtD
Idarubicin—Anaemia—Methotrexate—germ cell cancer	5.91e-05	0.000748	CcSEcCtD
Idarubicin—CYP2D6—female gonad—germ cell cancer	5.84e-05	0.0103	CbGeAlD
Idarubicin—Leukopenia—Methotrexate—germ cell cancer	5.72e-05	0.000725	CcSEcCtD
Idarubicin—Nausea—Cisplatin—germ cell cancer	5.65e-05	0.000715	CcSEcCtD
Idarubicin—Convulsion—Methotrexate—germ cell cancer	5.54e-05	0.000701	CcSEcCtD
Idarubicin—Vomiting—Etoposide—germ cell cancer	5.54e-05	0.000701	CcSEcCtD
Idarubicin—Rash—Etoposide—germ cell cancer	5.49e-05	0.000696	CcSEcCtD
Idarubicin—Dermatitis—Etoposide—germ cell cancer	5.48e-05	0.000695	CcSEcCtD
Idarubicin—Headache—Etoposide—germ cell cancer	5.45e-05	0.000691	CcSEcCtD
Idarubicin—Chest pain—Methotrexate—germ cell cancer	5.44e-05	0.000689	CcSEcCtD
Idarubicin—CYP2D6—endocrine gland—germ cell cancer	5.43e-05	0.0096	CbGeAlD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	5.4e-05	0.000685	CcSEcCtD
Idarubicin—CYP2D6—head—germ cell cancer	5.36e-05	0.00948	CbGeAlD
Idarubicin—Anaphylactic shock—Methotrexate—germ cell cancer	5.22e-05	0.000661	CcSEcCtD
Idarubicin—Infection—Methotrexate—germ cell cancer	5.18e-05	0.000656	CcSEcCtD
Idarubicin—CYP2D6—testis—germ cell cancer	5.18e-05	0.00915	CbGeAlD
Idarubicin—Nausea—Etoposide—germ cell cancer	5.17e-05	0.000655	CcSEcCtD
Idarubicin—Thrombocytopenia—Methotrexate—germ cell cancer	5.11e-05	0.000647	CcSEcCtD
Idarubicin—Skin disorder—Methotrexate—germ cell cancer	5.07e-05	0.000642	CcSEcCtD
Idarubicin—Anorexia—Methotrexate—germ cell cancer	4.97e-05	0.00063	CcSEcCtD
Idarubicin—CYP2D6—cerebellum—germ cell cancer	4.78e-05	0.00845	CbGeAlD
Idarubicin—Decreased appetite—Methotrexate—germ cell cancer	4.53e-05	0.000574	CcSEcCtD
Idarubicin—Gastrointestinal pain—Methotrexate—germ cell cancer	4.26e-05	0.00054	CcSEcCtD
Idarubicin—Urticaria—Methotrexate—germ cell cancer	4.14e-05	0.000525	CcSEcCtD
Idarubicin—Body temperature increased—Methotrexate—germ cell cancer	4.12e-05	0.000522	CcSEcCtD
Idarubicin—Abdominal pain—Methotrexate—germ cell cancer	4.12e-05	0.000522	CcSEcCtD
Idarubicin—CYP2D6—brain—germ cell cancer	3.88e-05	0.00687	CbGeAlD
Idarubicin—Hypersensitivity—Methotrexate—germ cell cancer	3.84e-05	0.000487	CcSEcCtD
Idarubicin—Diarrhoea—Methotrexate—germ cell cancer	3.57e-05	0.000452	CcSEcCtD
Idarubicin—Vomiting—Methotrexate—germ cell cancer	3.32e-05	0.00042	CcSEcCtD
Idarubicin—Rash—Methotrexate—germ cell cancer	3.29e-05	0.000417	CcSEcCtD
Idarubicin—Dermatitis—Methotrexate—germ cell cancer	3.29e-05	0.000416	CcSEcCtD
Idarubicin—Headache—Methotrexate—germ cell cancer	3.27e-05	0.000414	CcSEcCtD
Idarubicin—Nausea—Methotrexate—germ cell cancer	3.1e-05	0.000392	CcSEcCtD
